Bioventus Inc.BVSNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank72
5Y CAGR-6.6%
Year-over-Year Change
Year-over-year gross profit growth rate
5Y CAGR
-6.6%/yr
Long-term compound
Percentile
P72
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 12.52% |
| Q3 2025 | -9.07% |
| Q2 2025 | 22.92% |
| Q1 2025 | -19.09% |
| Q4 2024 | 9.73% |
| Q3 2024 | -9.73% |
| Q2 2024 | 17.27% |
| Q1 2024 | 2.41% |
| Q4 2023 | 9.45% |
| Q3 2023 | -11.53% |
| Q3 2023 | 20.57% |
| Q2 2023 | -0.36% |
| Q4 2022 | -12.24% |
| Q4 2022 | -12.54% |
| Q3 2022 | 27.68% |
| Q2 2022 | -13.75% |
| Q4 2021 | 11.00% |
| Q4 2021 | 3.61% |
| Q3 2021 | 28.14% |
| Q2 2021 | -18.94% |
| Q4 2020 | 17.62% |
| Q3 2020 | 54.81% |
| Q2 2020 | -29.50% |
| Q1 2020 | -22.05% |
| Q4 2019 | 21.26% |
| Q3 2019 | 5.12% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q1 2016 | 0.00% |
| Q1 2015 | 0.00% |